Incorporation of thiotepa in a reduced intensity conditioning regimen may improve engraftment after transplant for HLH-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Incorporation of thiotepa in a reduced intensity conditioning regimen may improve engraftment after transplant for HLH

Published:2020-01-27 Issue:6 Volume:188 Page:
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Naik Swati¹²³^ORCID,Eckstein Olive²³,Sasa Ghadir¹²³,Heslop Helen E.¹²³⁴,Krance Robert A.¹²³,Allen Carl¹²³,Martinez Caridad¹²³

Affiliation:

1. Center for Cell and Gene Therapy Texas Children’s Hospital Baylor College of Medicine Houston Methodist Hospital Houston TX USA

2. Texas Children's Cancer Center Texas Children’s Hospital Baylor College of Medicine Houston TX USA

3. Department of Pediatrics Baylor College of Medicine Houston TX USA

4. Department of Medicine Baylor College of Medicine Houston TX USA

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.16370

Reference14 articles.

1. Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficiencies

2. Unrelated donor hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis

3. Fludarabine, melphalan, thiotepa and anti-thymocyte globulin conditioning for unrelated cord blood transplant

4. The use of reduced-intensity stem cell transplantation in haemophagocytic lymphohistiocytosis and Langerhans cell histiocytosis

5. Clinical Aspects of STAT3 Gain-of-Function Germline Mutations: A Systematic Review

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unrelated umbilical cord blood transplantation using a noval conditioning regimen for small month-old infants with rare non-malignant disorders;2024-08-26

2. Age Impacts Risk of Mixed Chimerism Following Reduced-Intensity Conditioning Hematopoietic Cell Transplantation for Non-Severe Combined Immune Deficiency Inborn Errors of Immunity;Transplantation and Cellular Therapy;2024-01

3. Salvage Therapy and Allogeneic Hematopoietic Cell Transplantation for the Severe Cytokine Storm Syndrome of Hemophagocytic Lymphohistiocytosis;Advances in Experimental Medicine and Biology;2024

4. Hematopoietic Bone Marrow Transplant to Treat Systemic EBV-positive T-cell Lymphoma of Childhood;Journal of Pediatric Hematology/Oncology;2023-12-20

5. Alemtuzumab and CXCL9 levels predict likelihood of sustained engraftment after reduced-intensity conditioning HCT;Blood Advances;2023-07-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3